Mr. Spencer is the co-founder of Surgical Biologics, a leading processor of amnion tissue for use in a variety of surgical implants. Since the founding of Surgical Biologics in 2006, he led the development of the proprietary PURION® Process,
Uncategorized
Frank Burrows
Mr. Burrows joined MiMedx Group in April 2011 as Vice President of Wound Care to lead the marketing of the Company’s wound care offerings and other exciting products and tissues. He assumed the role Of Vice President of Global Marketing in August 2011 to focus on expanding the Company’s presence in the regenerative tissue market.
Rebeccah J. C. Brown, Ph.D.
Dr. Brown joined SpineMedica LLC, an early-stage predecessor company to MiMedx, in 2005. She initially served as the Director of Project Management and Senior Engineer for SpineMedica, and later served as its Director of Research and Development and as Vice President of Operations.
Jack Howarth
Jack Howarth joined MiMedx in December 2020. Prior to joining the Company, Mr. Howarth served as Vice President, Corporate Affairs at Antares Pharmaceuticals. Previously, he served as head of corporate and investor relations at King Pharmaceuticals until the acquisition by Pfizer; and held senior leadership positions in Corporate Affairs at Alpharma, KOS Pharmaceuticals and Elan … Read more
David H. Mason, Jr., M.D.
Dr. Mason was named the Company’s Chief Medical Officer in December 2018. He joined MiMedx in June 2014, in the position of Vice President of Medical Affairs for Clinical Programs. Dr. Mason is a Board Certified Internist, board eligible in Rheumatology and Infectious Diseases, whose experience includes a 27-year pharmaceutical and medical device industry career, with increasing levels of responsibility.